INDIUM IN-111 PENTETREOTIDE KIT Drug Patent Profile

Which patents cover Indium In-111 Pentetreotide Kit, and what generic alternatives are available?

Indium In-111 Pentetreotide Kit is a drug marketed by Sun Pharm Inds Inc and is included in one NDA.

The generic ingredient in INDIUM IN-111 PENTETREOTIDE KIT is indium in-111 pentetreotide kit. There are twenty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indium in-111 pentetreotide kit profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Indium In-111 Pentetreotide Kit

A generic version of INDIUM IN-111 PENTETREOTIDE KIT was approved as indium in-111 pentetreotide kit by SUN PHARM INDS INC on July 1^st, 2024.

Summary for INDIUM IN-111 PENTETREOTIDE KIT

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	5
DailyMed Link:	INDIUM IN-111 PENTETREOTIDE KIT at DailyMed

Recent Clinical Trials for INDIUM IN-111 PENTETREOTIDE KIT

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University Hospital Inselspital, Berne	Phase 1/Phase 2
University Hospital, Basel, Switzerland	Phase 1/Phase 2
University of Lausanne Hospitals	Phase 1/Phase 2

See all INDIUM IN-111 PENTETREOTIDE KIT clinical trials

US Patents and Regulatory Information for INDIUM IN-111 PENTETREOTIDE KIT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Inc	INDIUM IN-111 PENTETREOTIDE KIT	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	212785-001	Jul 1, 2024	AP	RX	No	No